RhoVac AB announced on September 18, 2018, that the company has recruited Dr. Steven Glazer to the position of Medical Director (MD), commencing immediately. Steven's previous assignments include Senior Vice President Development at Bioinvent International AB, Director of Haematology at Novo Nordisk AS and Chief Medical Officer at Hansa Medical AB. In parallel with the part-time assignment at RhoVac, Steven continues his work as Chief Medical Officer at Idogen AB and Board Member of Immunicum AB.